Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer. | Mol Med | 2022 | 35715741 | PubTator, text mining | PubMed |
| Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis. | J Clin Invest | 2022 | 35703178 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses. | Front Neurol | 2022 | 35693009 | PubTator, text mining | PubMed |
| Unraveling the Pathogenesis of Asthma and Chronic Obstructive Pulmonary Disease Overlap: Focusing on Epigenetic Mechanisms. | Cells | 2022 | 35681424 | PubTator, text mining | PubMed |
| The Immunological Roles of Olfactory Ensheathing Cells in the Treatment of Spinal Cord Injury. | Front Immunol | 2022 | 35669779 | PubTator, text mining | PubMed |
| The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness. | Nat Cell Biol | 2022 | 35668135 | PubTator, text mining | PubMed |
| Lung Cancer Induces NK Cell Contractility and Cytotoxicity Through Transcription Factor Nuclear Localization. | Front Cell Dev Biol | 2022 | 35652099 | PubTator, text mining | PubMed |
| Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemogenesis. | Nat Commun | 2022 | 35650206 | PubTator, text mining | PubMed |
| EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance. | World J Gastrointest Oncol | 2022 | 35646281 | PubTator, text mining | PubMed |
| The perception and response of T cells to a changing environment are based on the law of initial value. | Sci Signal | 2022 | 35639856 | PubTator, text mining | PubMed |
| PTPN22: structure, function, and developments in inhibitor discovery with applications for immunotherapy. | Expert Opin Drug Discov | 2022 | 35637605 | PubTator, text mining | PubMed |
| Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance. | Cancers (Basel) | 2022 | 35625999 | PubTator, text mining | PubMed |
| Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality. | Cancers (Basel) | 2022 | 35625998 | PubTator, text mining | PubMed |
| An NF-κB- and Therapy-Related Regulatory Network in Glioma: A Potential Mechanism of Action for Natural Antiglioma Agents. | Biomedicines | 2022 | 35625673 | PubTator, text mining | PubMed |
| Engineering γδ T Cells: Recognizing and Activating on Their Own Way. | Front Immunol | 2022 | 35603176 | PubTator, text mining | PubMed |
| Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients. | Proc Natl Acad Sci U S A | 2022 | 35588454 | PubTator, text mining | PubMed |
| T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma. | J Cell Mol Med | 2022 | 35586951 | PubTator, text mining | PubMed |
| Integration of human inspection and artificial intelligence-based morphological typing of patient-derived organoids reveals interpatient heterogeneity of colorectal cancer. | Cancer Sci | 2022 | 35585758 | PubTator, text mining | PubMed |
| Spatially resolved in silico modeling of NKG2D signaling kinetics suggests a key role of NKG2D and Vav1 Co-clustering in generating natural killer cell activation. | PLoS Comput Biol | 2022 | 35584138 | PubTator, text mining | PubMed |
| Dual regulation of the actin cytoskeleton by CARMIL-GAP. | J Cell Sci | 2022 | 35583107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=24